The complexity of our cohort allowed for the first time comparison of breakpoint distribution in CML vs. BCR::ABL1-positive ALL, revealing significant differences in both ABL1 and Major BCR loci. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.